PTSM: Pharmaceutical Technology Sourcing and Management, Mar 5, 2014 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Mar 5, 2014
Manufacturing, Outsourcing
Top 10 Outsourcing Trends in Biopharmaceutical Manufacturing
By Eric Langer
In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.
Contract Services
Metrics Expands with Fast-Track Development Laboratory
By Melanie Sena
Metrics opens a new laboratory to support fast-track development of pharmaceutical products in North Carolina.
Croda Receives Two EXCiPACT Certifications
Croda receives two achievements in relation to EXCiPACT.
AbbVie Expands Manufacturing Presence in Singapore
By Melanie Sena
AbbVie will open its first manufacturing facility in Singapore.
Almac Adds New Blistering Technology
Almac has added new blistering technology at their US packaging facility in Audubon, PA, as a solution to ease the transition between clinical and commercial launch of blister products.
GMP Certification Extended for Cobra Biologics
By Melanie Sena
Cobra Biologics' GMP Compliance Certification has been extended to include QC testing.
Outsourcing
Alternative Expression Systems May Cut Bioprocessing Costs, Open New CMO Opportunities
By Eric Langer
Novel expression systems such as plant-based manufacturing platforms are expected to dramatically lower manufacturing costs. How will the market respond with outsourcing options?
API Synthesis & Manufacturing
Demand Increases for Novel Excipients, but Manufacturers Still Face Challenges
By Cynthia Challener, PhD
Drug formulators are looking for new excipients to address solubility and bioavailability issues and extend patent protection, but there are hurdles to using novel, specialized ingredients.
Regulatory Initiatives Spur API Supply Chain Security
By Cynthia Challener, PhD
In order to ensure a safe drug supply chain, governments have implemented both legislated and voluntary programs designed to address problem areas.
Supply Chain
Ranbaxy Suspends API Shipments from Two Plants in India
Daiichi Sankyo announced suspension of API shipments from Ranbaxy's Toansa and Dewas plants; issues apology to stakeholders.
FDA Initiates Secure Supply Chain Pilot Program
Thirteen companies are accepted for participation in the supply chain program.
Outsourcing
Local Knowledge Drives Global Market Expansion
Pharma companies entering new regional markets can find expertise in local regulations and business customs through outsourced services.
Reaching China's Clinical Trial Market
Geographic location, customs and drug-development regulations knowledge, and transportation infrastructure were factors in Catalent Pharma Solutions? selection of Shanghai for its clinical-trials supply facility.
CSR and Sustainability Forum
Inflammatory Diseases Explained in Artistic Designs
By Melanie Sena
AbbVie launches art initiative designed to explore impact of chronic inflammatory diseases.
MedImmune Announces Research Collaboration with UC SanFrancisco
MedImmune and AstraZeneca enter a three-year collaboration with the Clinical and Translational Science Institute at the UC San Francisco.
Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program
Lilly Diabetes supports the American Diabetes Association for the seventh year in a row.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here